LifePort Liver Transporter | Transforming Preservation

Over 2,300 patients in the United States were removed from the liver transplant waiting list in 2021, either because they died waiting for a donor liver or were deemed too sick to be transplanted. Increasing the number of organs available for transplantation, while reducing post-transplantation complications and shortening the length of hospital stay, are important clinical goals to improve patient outcomes.

In this video, learn how LifePort Liver Transporter is working to transform preservation of donor livers. LifePort Liver Transporter (LLT) is a hypothermic oxygenated machine perfusion (HMP-O2) system that preserves and protects a donated liver. This portable medical device is designed to optimize liver health during preservation for clinical transplantation. Results from the clinical trial show a reduction in the number of graft failures, increased lactate clearance, and improved bile production following the transplant of perfused livers.
https://www.organ-recovery.com/